J.C. Horiot

Rationale, Technical Parameters and Indications of External Irradiation in the Management of Carcinoma of the Endometrium

J.C. Horiot

European Organization for Research on Treatment of Cancer Trials Using Radiotherapy with Multiple Fractions per Day

J.C. Horiot, W. Van den Bogaert, K. Kian Ang, Emmanuel van der Schueren et autres

fr, be, us, nl (code pays fourni par la source)

Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial

Harry Bartelink, P. Maingon, Philip Poortmans, Caroline Weltens et autres

nl, fr, be, ch, de, gb (code pays fourni par la source)

46 speaker: 50 Years of Progress in Oncology: Which Future Left for Brachytherapy?

J.C. Horiot

IVB.2 Combining radiation therapy and chemotherapy: feasible in the elderly?

J.C. Horiot

2027 ORAL Predictors of increased risk of breast fibrosis at 10 years with higher radiation dose in the early breast cancer (EORTC “Boost versus no Boost” trial 22881–10882).

Sandra Collette, Laurence Collette, Tom Budiharto, J.C. Horiot et autres

Hyperfractioned or accelerated radiotherapy in head and neck cancer: a meta‐analysis

Jean Bourhis, Jens Overgaard, Hélène Audry, Kian Ang et autres

The use of the BCT in the population included in the EORTC22922/10925 investigating elective lymph node irradiation comparing with 22881/10882 investigating the role of a boost in early breast cancer

E. Musat, Poortmans, Harry Bartelink, W. Van den Bogaert et autres

The positive influence of quality assurance in 2 consecutive large EORTC trials involving radiotherapy for breast cancer

P Poortmans, H. Struikmans, J.B. Davis, B.J. Mijnheer et autres

S7.2 The role of radiotherapy and concomitantradiochemotherapy

J.C. Horiot

Conservative treatment of early glottic carcinomas with exclusive radiotherapy

Juliette Thariat, Y. Bruchon, Franck Bonnetain, I. Barillot et autres

fr (code pays fourni par la source)

Meta-analysis of conventional versus altered fractionated radiotherapy in head and neck squamous cell carcinoma (HNSCC): Final analysis

Jean Bourhis, Hélène Audry, Jens Overgaard, K. Kian Ang et autres

fr, us, gb, be, pl, it (code pays fourni par la source)